Annual FCF
-$8.91 M
+$8.33 M+48.31%
01 December 2023
Summary:
Addex Therapeutics Ltd annual free cash flow is currently -$8.91 million, with the most recent change of +$8.33 million (+48.31%) on 01 December 2023. During the last 3 years, it has risen by +$4.15 million (+31.76%). ADXN annual FCF is now -600.08% below its all-time high of $1.78 million, reached on 31 December 2018.ADXN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$713.30 K
+$2.25 M+75.94%
01 September 2024
Summary:
Addex Therapeutics Ltd quarterly free cash flow is currently -$713.30 thousand, with the most recent change of +$2.25 million (+75.94%) on 01 September 2024. Over the past year, it has dropped by -$155.80 thousand (-27.95%). ADXN quarterly FCF is now -173.62% below its all-time high of $968.90 thousand, reached on 31 December 2020.ADXN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$6.75 M
+$1.94 M+22.32%
01 September 2024
Summary:
Addex Therapeutics Ltd TTM free cash flow is currently -$6.75 million, with the most recent change of +$1.94 million (+22.32%) on 01 September 2024. Over the past year, it has increased by +$2.16 million (+24.28%). ADXN TTM FCF is now -161.89% below its all-time high of -$2.58 million, reached on 31 March 2019.ADXN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADXN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -27.9% | +24.3% |
| 3 y3 years | +31.8% | +73.5% | +43.1% |
| 5 y5 years | -600.1% | +85.9% | +30.3% |
ADXN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +48.3% | -27.9% | +87.7% | at high | +63.1% |
| 5 y | 5 years | -600.1% | +48.3% | -173.6% | +89.9% | at high | +63.1% |
| alltime | all time | -600.1% | +77.9% | -173.6% | +89.9% | -161.9% | +63.1% |
Addex Therapeutics Ltd Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$713.30 K(-75.9%) | -$6.75 M(-22.3%) |
| June 2024 | - | -$2.96 M(+18.1%) | -$8.68 M(-2.1%) |
| Mar 2024 | - | -$2.51 M(+350.4%) | -$8.87 M(-0.4%) |
| Dec 2023 | -$8.91 M(-48.3%) | -$557.50 K(-79.0%) | -$8.91 M(-24.2%) |
| Sept 2023 | - | -$2.65 M(-15.8%) | -$11.75 M(-1.1%) |
| June 2023 | - | -$3.15 M(+23.5%) | -$11.87 M(-18.3%) |
| Mar 2023 | - | -$2.55 M(-24.9%) | -$14.54 M(-15.6%) |
| Dec 2022 | -$17.24 M(+6.9%) | -$3.40 M(+22.2%) | -$17.24 M(+0.5%) |
| Sept 2022 | - | -$2.78 M(-52.2%) | -$17.15 M(+0.5%) |
| June 2022 | - | -$5.82 M(+10.9%) | -$17.05 M(-6.8%) |
| Mar 2022 | - | -$5.25 M(+58.7%) | -$18.30 M(+13.5%) |
| Dec 2021 | -$16.12 M(+23.5%) | -$3.31 M(+23.0%) | -$16.12 M(+36.1%) |
| Sept 2021 | - | -$2.69 M(-62.0%) | -$11.85 M(-4.9%) |
| June 2021 | - | -$7.07 M(+130.6%) | -$12.46 M(+5.5%) |
| Mar 2021 | - | -$3.06 M(-416.3%) | -$11.81 M(-9.5%) |
| Dec 2020 | -$13.05 M | $968.90 K(-129.4%) | -$13.05 M(-6.2%) |
| Sept 2020 | - | -$3.30 M(-48.6%) | -$13.92 M(-11.2%) |
| June 2020 | - | -$6.42 M(+49.0%) | -$15.67 M(+38.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$4.31 M(-4412.6%) | -$11.31 M(+18.1%) |
| Dec 2019 | -$9.57 M(-637.4%) | $99.90 K(-102.0%) | -$9.57 M(-1.0%) |
| Sept 2019 | - | -$5.05 M(+146.3%) | -$9.67 M(+109.1%) |
| June 2019 | - | -$2.05 M(-20.4%) | -$4.62 M(+79.6%) |
| Mar 2019 | - | -$2.58 M | -$2.58 M |
| Dec 2018 | $1.78 M(-182.0%) | - | - |
| Dec 2017 | -$2.17 M(-20.9%) | - | - |
| Dec 2016 | -$2.75 M(+0.6%) | - | - |
| Dec 2015 | -$2.73 M(+38.7%) | - | - |
| Dec 2014 | -$1.97 M(-88.4%) | - | - |
| Dec 2013 | -$17.02 M(-46.4%) | - | - |
| Dec 2012 | -$31.77 M(+4.9%) | - | - |
| Dec 2011 | -$30.28 M(-0.3%) | - | - |
| Dec 2010 | -$30.37 M(-24.6%) | - | - |
| Dec 2009 | -$40.26 M(+85.8%) | - | - |
| Dec 2008 | -$21.66 M(-27.3%) | - | - |
| Dec 2007 | -$29.80 M(+87.3%) | - | - |
| Dec 2006 | -$15.91 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual free cash flow?
- What is the all time high annual FCF for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly free cash flow?
- What is the all time high quarterly FCF for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly FCF year-on-year change?
- What is Addex Therapeutics Ltd TTM free cash flow?
- What is the all time high TTM FCF for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM FCF year-on-year change?
What is Addex Therapeutics Ltd annual free cash flow?
The current annual FCF of ADXN is -$8.91 M
What is the all time high annual FCF for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual free cash flow is $1.78 M
What is Addex Therapeutics Ltd quarterly free cash flow?
The current quarterly FCF of ADXN is -$713.30 K
What is the all time high quarterly FCF for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly free cash flow is $968.90 K
What is Addex Therapeutics Ltd quarterly FCF year-on-year change?
Over the past year, ADXN quarterly free cash flow has changed by -$155.80 K (-27.95%)
What is Addex Therapeutics Ltd TTM free cash flow?
The current TTM FCF of ADXN is -$6.75 M
What is the all time high TTM FCF for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM free cash flow is -$2.58 M
What is Addex Therapeutics Ltd TTM FCF year-on-year change?
Over the past year, ADXN TTM free cash flow has changed by +$2.16 M (+24.28%)